Bibliography

Bibliography

1. Hypertensive Disorders: Cunningham FG et al. Williams Obstetrics

24th Edition, McGraw-Hill Education, 2014; 728 – 779

2. Kofinas AD, Penry M, Swain M, Hatjis CG. Effect of placental

laterality on uterine artery resistance and development of preeclampsia

and intrauterine growth retardation. Am J Obstet Gynecol. 1989

Dec;161(6 Pt 1):1536-9.

3. Kofinas AD, Penry M, Greiss FC Jr, Meis PJ, Nelson LH. The effect of

placental location on uterine artery flow velocity waveforms. Am J Obstet

Gynecol. 1988 Dec;159(6):1504-8.

4. Pai Muralidhar V, Pillai J. Placental laterality by ultrasound- A

simple yet reliable predictive test for preeclampsia. J Obstet Gynecol

India. 2005; 55: 431-3

5. Ito Y, Shono H, Muro M, Uchiyama A, Sugimori H. Resistance index

of uterine artery and placental location in IUGR. Acta Obstet Gynecol

Scand 1998; 77: 385-390.

6. Meekins J W, Prijnenborg R, Hansenns M, McFayden IR, Van Asshe

A. A study of placental bed spiral arteries and trophoblastic invasion in

Page | 92
 Bibliography

normal and severe pre-eclamptic pregnancies. Br J Obstet Gynecol 1994;

101: 669-674

7. North RJ, Ferrier C, Long D, Townend K, Kincaid-Smith P. Uterine

artery doppler flow velocity waveforms in the second trimester for the

prediction of pre-eclampsia and IUGR. Obstet Gynecol 1994; 83: 378-386.

8. Walker JJ. Current thoughts on the pathophysiology of

preeclampsia / eclampsia. In: John Studd (ed). Progress in Obstetrics and

Gynecology, Edinburgh.Churchill-Livingstone.1998: 177-88.

9. Schulman H, Winter D, Farmakides G et al. Pregnancy surveillance

with Doppler velocimetry of uterine and umbilical arteries. Am J Obstet

Gynecol 1989;160:192-6.

10. Campbell S, Pearce JM, Hackett G et al. Qualitative assessment of

uteroplacental blood flow: early screening test for high risk pregnancies.

Obstet Gynecol 1986;68:649-53.

11. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate

maternal vascular response to placentation in pregnancies complicated

by pre-eclampsia and by small-for-gestational age infants. Br J Obstet

Gynaecol1986; 93: 1049–1059.

Page | 93
 Bibliography

12. Bhalerao AV , Kulkarni S ,Somalwar S . Lateral Placentation by

USG: A Simple Predictor of Preeclampsia .J South Asian Feder Obst Gynae

2013 ;5(2):68-71.

13. Brosens, I. & Dixon, H. G. (1966) Anatomy of the maternal side of

the placenta. J Obstet Gynaecol Br Commonw 73, 357-363

14. Boyd, J. D. & Hamilton, W. J. (1970) The Human Placenta. Heffer

and Sons, Cambridge.

15. Pijnenborg, R., Dixon, G., Robertson, W. B. & Brosens, I. (1981) The

pattern of interstitial trophoblastic invasion of the myometrium in early

human pregnancy. Placenta 2,303-316.

16. Robertson, W. B., Brosens, I. & Dixon, H. G. (1967) The pathological

response of the vessels of the placental bed to hypertensivepregnancy. J

Pathol Bacterial 93, 581-592.

17. Browne, J. C. M. & Veall, N. (1953) The maternal placental blood

flow in normotensive and hypertensive women. J Obstet Gynaecol Br Emp

60,141 147.

18. Dixon, H. G . , Browne, J. C. M. & Davey, D. A. (1963) Choriodecidual

and myometrial blood flow. Lancet i, 369-373.

Page | 94
 Bibliography

19. Lunell, N. O., Sarby, B., Lewander, R. & Nylund, L. (1979)

Comparison of uteroplacental blood flow in normal and in intrauterine

growth-retarded pregnancy. Gynecol Obstet Invest 10, 106-115

20. Clavero-Nunez, J. A. (1980) Uteroplacental bloodflow in pregnancy

at term. In Clinical Perinatology (Aladjem, S., Brown, A. K. & Sureau, C.,

eds) Mosby, St Louis, pp. 294-309

21. Campbell, S., Diaz-Recasens, J., Griffin, D. R., Cohen-Overbeek, T.

E., Pearce, J. M., Willson, K. &Teague, M. J. (1983) New Doppler technique

for assessing uteroplacental blood flow. Lancet i, 675-671

22. Trudinger, B. J., Giles, W. B. & Cook, C . M.(1985) Uteroplacental

blood flow velocity-time waveforms in normal and complicated

pregnancy. Br J Obstet GynaecoI 92,39-45.

23. Pearce, J. M., Khong, T. Y.,Campbell, S.& Robertson, W. B. (1986)

Do Doppler flow velocity waveforms reflect placental invasion? Obstet

Gynecol inpress.

24. Brosens, I., Dixon, H. G. & Robertson, W. B. (1977) Fetal growth

retardation and the arteries of the placental bed. Br J Obstet Gynaecol84,

656-663

Page | 95
 Bibliography

25. Robertson, W. B., Brosens, I. & Dixon, G. (1975) Uteroplacental

vascular pathology. Eur J Obstet Gynecol Reprod Biol5,47-65.

26. Sheppard, B. L. & Bonnar, J. (1976) The ultrastructure of the arterial

supply of the human placenta in pregnancy complicated by fetal growth

retardation. Br J Obstet Gynuecol83,948-959.

27. Harris, J. W. S. & Ramsey, E. M. (1966) The morphology of human

uteroplacental vasculature. Contrib Embryo1 38, 43-58.

28. Dalgaard, D. B. (1946) Blood vessels of the human endometrium.

Acta Obstet Gynecol Scand 26,342-378

29. Lundgren, N. (1957) Studies on the vasculature of the corpus of the

human uterus. Acta Obstet Gynecol Scand 36, (suppl 4), 1-115

30. Althabe, O.,Labarre, C. &Telenta, M. (1985) Maternal vascular

lesions in placentae of small-forgestational age infants. Placenta 6, 265-

276.

31. Fleischer A, Schulman H, Farmakides G et al. Uterine artery

Doppler velocimetry in pregnant women with hypertension. Am J Obstet

Gynecol 1986;154:806-13

Page | 96
 Bibliography

32. Schulman H, Winter D, Farmakides G et al. Pregnancy surveillance

with Doppler velocimetry of uterine and umbilical arteries. Am J Obstet

Gynecol 1989;160:192-6

33. Harris D. Robert, Alexander D. Roberta. Ultrasound of the placenta

and umbilical cord. Ultrasonography in obstetrics and gynaecology by

Callen: 4th ed, 2000. Philadelphia: WB. Saunders Company, Philadelphia:

597.

34. Chan FY, Pun TC, Lam C et al. Pregnancy screening by uterine

artery Doppler velocimetry – which criterion performs best ? Obstet

Gynecol 1995;85:596-602

35. Hoogland HJ, deHaan J. Ultrasonographic placental localization

with respect to fetal position in utero. Eur J Obstet Gynecol Reprod Bioi

1980; 11 :9.

36. Harris VG. Relation between placental site and length of gestation.

Br J Obstet Gynaecol 1975;82:581.

37. Davydov SN, Orlov VM, Samorodinova LA, Khrustalkov SV.

Location of placenta and clinical course of labour. Acta Chir Hung

1987;28:3.

Page | 97
 Bibliography

38. Booth RT, Wood C, Beard RW, Gibson JRM, Pinkerton JHM.

Significance of site of placental attachment in uterus. Br MedJ

1962;1:1732.

39. Little WA, Friedman EA. Significance of the placental position.

Obstet Gynecol 1964;23:804.

40. EF Magann, DA Doherty, K Turner, GS Lanneau Jr, JC Morrison and

JP Newnham. Second trimester placental location as a predictor of an

adverse pregnancy outcome. Journal of Perinatology (2007) 27, 9–14

41. Sandhya K., Madhavi G.B. and Chandramathi M. Placental

Laterality as a Predictor of Preeclampsia. AJPCT[3][03][2015] 231-236

42. Department of Health. Why mothers die. Report on

confidentialinquiries into maternal deaths in the United Kingdom 1994–

96. London: Stationery Office, 1999.

43. Leitch CR, Cameron AD, Walker JJ. The changing pattern of

eclampsia over a 60 year period. Br J Obstet Gynaecol 1997; 104: 917–22.

44. Duley L. Maternal mortality associated with hypertensive

disorders of pregnancy in Africa, Asia, Latin America and the Caribbean.

Br J Obstet Gynaecol 1992; 99: 547–53.

Page | 98
 Bibliography

45. Sibai BM. Prevention of preeclampsia: a big disappointment. Am J

Obstet Gynecol 1998; 179: 1275–78.

46. Walker JJ. Day-care obstetrics. Br J Hosp Med 1993; 50: 225–26.

47. Plouin PF, Breart G, Rabarison Y, Sureau C, Rumeau-Rouquette C,

Menard J. Incidence and fetal impact of hypertension in pregnancy: study

of 2996 pregnancies. Arch Mal Coeur Vaiss 1982; 75: 5–7.

48. Levine RJ, Hauth JC, Curet LB, et al. Trial of calcium to prevent pre-

eclampsia. N Engl J Med 1997; 337: 69–76.

49. Knight M, Duley L, Henderson-Smart DJ, King JF. Antiplatelet

agents for preventing and treating pre-eclampsia. Cochrane Library.

Oxford: Upate Software, 2000 (Issue 2).

50. Sibai BM, Caritis SN, Thom E, et al. Prevention of preeclampsia

with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J

Med 1993; 329: 1213–18.

51. Sibai BM, Ramadan MK, Chari RS, Friedman SA. Pregnancies

complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and

low platelets): subsequent pregnancy outcome and long-term prognosis.

Am J Obstet Gynecol 1995; 172: 125–29.

Page | 99
 Bibliography

52. Magee LA, Ornstein MP, von Dadelszen P. Management of

hypertension in pregnancy. BMJ 1999; 318: 1332–36.

53. Caritis S, Sibai B, Hauth J, et al. Low-dose aspirin to prevent

preeclampsia in women at high risk. N Engl J Med 1998; 338: 701–05.

54. Sibai BM, Abdella TN, Anderson GD. Pregnancy outcome in 211

patients with mild chronic hypertension. Obstet Gynecol 1983; 61: 571–

76.

55. Trupin LS, Simon LP, Eskenazi B. Change in paternity: a risk factor

for preeclampsia in multiparas. Epidemiology 1996; 7: 240–44.

56. Lie RT, Rasmussen S, Brunborg H, Gjessing HK, Lie-Nielsen E, Irgens

LM. Fetal and maternal contributions to risk of pre-eclampsia: population

based study. BMJ 1998; 316: 1343–47.

57. Salha O, Sharma V, Data T, et al. The influence of donated gametes

on the incidence of hypertensive disorders of pregnancy. Hum Reprod

1999; 14: 2268–73.

58. 17 Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive

maternal inflammatory response to pregnancy. Am J Obster Gynecol

1999; 180: 499–506.

Page | 100
 Bibliography

59. Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe

A. A study of placental bed spiral arteries and trophoblast invasion in

normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 1994;

101: 669–74.

60. Macara L, Kingdom JC, Kaufmann P, et al. Structural analysis of

placental terminal villi from growth-restricted pregnancies with

abnormal umbilical artery doppler waveforms. Placenta 1996; 17: 37–48.

61. Sheppard BL, Bonnar J. An ultrastructural study of utero-placental

spiral arteries in hypertensive and normotensive pregnancy and fetal

growth retardation. Br J Obstet Gynaecol 1981; 88: 695–705.

62. Roberts JM, Hubel CA, Taylor RN. Endothelial dysfunction yes,

cytotoxicity no. Am J Obstet Gynecol 1995; 173: 978–79.

63. Pijnenborg R, McLaughlin PJ, Vercruysse L, et al.

Immunolocalization of tumour necrosis factor-alpha (TNF-alpha) in the

placental bed of normotensive and hypertensive human pregnancies.

Placenta 1998; 19: 231–39.

64. Arngrimsson R, Bjornsson , Geirsson RT, Bjornsson H, Walker JJ,

Snaedal G. Genetic and familial predisposition to eclampsia and pre-

Page | 101
 Bibliography

eclampsia in a defined population. Br J Obstet Gynaecol 1990; 97: 762–

69.

65. Broughton Pipkin F. What is the place of genetics in the

pathogenesis of pre-eclampsia? Biol Neonat 1999; 76: 325–30.

66. Martin JN Jr, May WL, Magann EF, Terrone DA, Rinehart BK, Blake

PG. Early risk assessment of severe preeclampsia: admission battery of

symptoms and laboratory tests to predict likelihood of subsequent

signifiant maternal morbidity. Am J Obstet Gynecol 1999; 180: 1407–14.

67. Brown MA, Buddle ML, Farrell T, Davis G, Jones M. Randomised

trial of management of hypertensive pregnancies by Korotkoff phase IV

or phase V. Lancet 1998; 352: 777–81.

68. Bosio PM, McKenna PJ, Conroy R, O’Herlihy C. Maternal central

hemodynamics in hypertensive disorders of pregnancy. Obstet Gynecol

1999; 94: 978–84.

69. Gartner HV, SamFmoun A, Wehrmann M, Grossman T, Junghans

R, Weihing C. Preeclamptic nephropathy—an endothelial lesion: a

morphological study with a review of the literature. Eur J Obstet Gynecol

Reprod Biol 1998; 77: 11–27.

Page | 102
 Bibliography

70. Brown MA, Buddle ML. Hypertension in pregnancy: maternal and

fetal outcomes according to laboratory and clinical features. Med J Aust

1996; 165: 360–65

71. Schiff E, Friedman SA, Kao L, Sibai BM. The importance of urinary

protein excretion during conservative management of severe

preeclampsia. Am J Obstet Gynecol 1996; 175: 1313–16.

72. Brown MA, Zammit VC, Lowe SA. Capillary permeability and

extracellular fluid volumes in pregnancy-induced hypertension. Clin Sci

1989; 77: 599–604

73. Sharma SK, Philip J, Whitten CW, Padakandla UB, Landers DF.

Assessment of changes in coagulation in paturients with preeclampsia

using thromboelastography. Anesthesiology 1999; 90: 385–90.

74. Saphier CJ, Repke JT. Hemolysis, elevated liver enzymes, and low

platelets (HELLP) syndrome: a review of diagnosis and management.

Semin Perinatol 1998; 22: 118–33.

75. Chan AD, Gerscovich EO. Imaging of subcapsular hepatic and renal

hematomas in pregnancy complicated by preeclampsia and the HELLP

syndrome. J Clin Ultrasound 1999; 27: 35–40.

Page | 103
 Bibliography

76. Sibai BM, Anderson GD, McCubbin JH. Eclampsia II: clinical

significance of laboratory findings. Obstet Gynecol 1982; 59: 153–57.

77. Stratta P, Besso L, Canavse C, et al. Is pregnancy-related acute

renal failure a disappearing clinical entity? Ren Fail 1996; 18: 575–84.

78. Naqvi R, Akhtar F, Ahmed E. Acute renal failure of obstetrical origin

during 1994 at one center. Ren Fail 1996; 18: 681–83.

79. Pavlakis SG, Frank Y, Chusid R. Hypertensive encephalopathy,

reversible occipitoparietal encephalopathy, or reversible posterior

leukoencephalopathy: three names for an old syndrome. J Child Neurol

1999; 14: 277–81.

80. Cunningham FG, Fernandez CO, Hernandez C. Blindness associated

with preeclampsia and eclampsia. Am J Obstet Gynecol 1995; 172: 1291–

98.

81. Magann EF, Perry KGJ, Chauhan SP, Graves GR, Blake PG, Martin

JNJ. Neonatal salvage by week’s gestation in pregnancies complicated by

HELLP syndrome. J Soc Gynecol Invest 1994; 1: 206–09.

82. Walker JJ. Care of the patient with severe pregnancy induced

hypertension. Eur J Obstet Gynecol Reprod Biol 1996; 65: 127–35.

Page | 104
 Bibliography

83. Saudin P, Brown MA, Buddle ML, Jones M. Does gestational

hypertension become pre-eclampsia? Br J Obstet Gynaecol 1998; 105:

1177–84.

84. Doubilet PM, Benson CB. Sonographic evaluation of intrauterine

growth retardation. AJR Am J Roentgenol 1995; 164: 709–17.

85. Dubinsky T, Lau M, Powell F, et al. Predicting poor neonatal

outcome: a comparative study of noninvasive antenatal testing methods.

AJR Am J Roentgenol 1997; 168: 827–31.

86. Hutton JD, James DK, Stirrat GM, Douglas KA, Redman CW.

Management of severe pre-eclampsia and eclampsia by UK consultants.

Br J Obster Gynaecol 1992; 99: 554–56.

87. Walker JJ. Hypertensive drugs in pregnancy: antihypertension

therapy in pregnancy, preeclampsia, and eclampsia. Clin Perinatol 1991;

18: 845–73.

88. Lydakis C, Lip GY, Beevers M, Beevers DG. Atenolol and fetal growth

in pregnancies complicated by hypertension. Am J Hypertens 1999; 12:

541–47.

Page | 105
 Bibliography

89. Collins R, Duley L. Any antihypertensive therapy for pregnancy

hypertension. Cochrane Library. Oxford: Update Software, 1994, Disk

Issue 1.

90. Brown MA, Whitworth JA. Management of hypertension in

pregnancy. Clin Exp Hypertens 1999; 21: 907–16.

91. Duley L, Carroli G, Belizan J, et al. Which anticonvulsant for women

with eclampsia? Lancet 1995; 345: 1455–63.

92. Sibai BM, Graham JM, McCubbin JH. A comparison of intravenous

and intramuscular magnesium sulfate regimens in preeclampsia. Am J

Obstet Gynecol 1984; 150: 728–33.

93. Witlin AG, Sibai BM. Magnesium sulfate therapy in preeclampsia

and eclampsia. Obstet Gynecol 1998; 92: 883–89.

94. Duley L, Gulmezoglu AM, Henderson-Smart DJ. Anticonvulsants for

pre-eclampsia. Cochrane Library. Oxford: Update Software, 1999.

95. Merrill JD, Ballard RA. Antenatal hormone therapy for fetal lung

maturation. Clin Perinatol 1998; 25: 983–97.

96. Nassar AH, Adra AM, Chakhtoura N, Gomez-Marin O, Beyodoun S.

Severe preeclampsia remote from term: labor induction or elective

caesarean delivery? Am J Obstet Gynecol 1998; 179: 1210–13.

97. Ramanathan J, Sibai BM, Mabie WC, Chauhan D, Ruiz AG. The use

of labetalol for attenuation of the hypertensive response endotracheal

intubation in preeclampsia. Am J Obstet Gynecol 1988; 159: 650–54

98. Hogg B, Hauth JC, Caritis SN, et al. Safety of labor epidural

anesthesia for women with severe hypertensive disease. Am J Obstet

Gynecol 1999; 181: 1096–101.

99. Sibai BM, Ramadan MK, et al. Maternal morbidity and mortality in

442 pregnancies with hemolysis, elevated liver enzymes and low platelets

(HELLP syndrome). Am J Obstet Gynecol 1993; 169: 1000–06.

100. Benedetti TJ, Kates R, Williams V. Hemodynamic observations in

severe preeclampsia complicated by pulmonary edema. Am J Obstet

Gynecol 1985; 152: 330–34.

101. Cotton DB, Gonik B, Dorman K, Harrist R. Cardiovascular

alterations in severe pregnancy-induced hypertension: relationship of

central venous pressure to pulmonary capillary wedge pressure. Am J

Obstet Gynecol 1985; 151: 762–64.

Page | 107
Bibliography

Page | 108